Please login to the form below

fitusiran

This page shows the latest fitusiran news and features for those working in and with pharma, biotech and healthcare.

FDA lifts clinical hold on Sanofi’s haemophilia drug

FDA lifts clinical hold on Sanofi’ s haemophilia drug. Phase II and III trials of fitusiran can now resume. ... A major obstacle facing Sanofi and Alnylam’s haemophilia therapy fitusiran has been removed, after the FDA lifted a clinical hold imposed

Latest news

Alnylam takes off on APOLLO trial results

Safety is an important finding as patient deaths have affected some of the firm's other programmes, including most recently haemophilia candidate fitusiran which had a trial halted as a result,
Solid start for Dupixent as Sanofi raises 2017 outlook

PD-1 in multiple cancer indications and fitusiran in haemophilia were significant R&D milestones in the second quarter".

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

instead taking a lead marketing role for their co- developed haemophilia candidate fitusiran. ... Alnylam has three more RNAi medicines in its late stage pipeline: Fitusiran in haemophilia, being co-developed with Sanofi; inclisiran for

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Director: £48, 000 - £60, 000

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Medical/ Scientific Director: Salary TBC

Consumer Health Account Director: Circa £60, 000 Gym and More

Senior Account Executive, London, Medical Communications: Excellent package

New Business Director - PR: Competitive Salary and benefits

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Account Manager / Senior Account Manager: 35, 000-40, 000

Associate Director, Market Access & HEOR – North-West: Negotiable

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Senior Medical Writer: Great salary and benefits

Senior Medical Writer: Competitive Salary

Project / Account Manager (Medical Education): Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Scientific Director / Editorial Team Leader: Great salary and benefits

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Production Manager – Healthcare Communications: DOE

Associate Director: £75, 000-90, 000

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Senior Medical Writer (Remote Working): Competitive Salary Offered

Subscribe to our email news alerts

PMHub

Add my company

Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...